Spyglass Pharma, Inc.
SEC CIK 1778922 · SPG · last insider filing 2026-02-11
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| RA Capital Healthcare Fund LP | Director | filed 2026 - 2026 |
| RA Capital Management, LLC | Director | filed 2026 - 2026 |
| Kolchinsky Peter | Director | filed 2026 - 2026 |
| Nielsen Kirk G. | Director | filed 2026 - 2026 |
| Behbahani Ali | Director | filed 2026 - 2026 |
| Shah Rajeev M. | Director | filed 2026 - 2026 |
| Pardo Geoffrey B | Director | filed 2026 - 2026 |
| RA Capital Nexus Fund III, L.P. | Director | filed 2026 - 2026 |
| Khan Bilal Arshad | Director | filed 2026 - 2026 |
| Dybbs Michael | Director | filed 2026 - 2026 |
| Dable Habib J | Director | filed 2026 - 2026 |
| O'Farrell Elizabeth G. | Director | filed 2026 - 2026 |
| Scheiner Zachary | Director | filed 2026 - 2026 |
| Kahook Malik Y. | Director · See remarks | filed 2026 - 2026 |
| Mooney Patrick H. | Director · Chief Executive Officer | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Viret Jean-Frederic | Chief Financial Officer | filed 2026 - 2026 |
| Dennewill James Robert Jr. | Chief Operating Officer | filed 2026 - 2026 |
| Pujara Chetan Pratap | Chief R&D Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.